Social participation using the AV1 robot in pediatric oncology - a pilot study

Social participation using the AV1 robot in pediatric oncology - a pilot study - STARK

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00039906

Enrollment

Registered

2026-04-13

Start date

2025-08-27

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

User acceptance, social participation, and quality of life associated with the use of the AV1 telepresence robot. C00-C97

Interventions

Group 1: Children and adolescents with cancer use the AV1 for a period of 3 months. A questionnaire will be used to assess user acceptance among the children/adolescents and their parents both before

Eligibility

Sex/Gender

All

Age

5 Years to No maximum

Inclusion criteria

Inclusion criteria: - Cancer - Starting from the first year of school - Admission subject to a medical assessment of the child’s health - Technical skills/experience using laptops, tablets, etc. (turning the tablet on and off, launching apps, using the on-screen keyboard, typing short messages)

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
The primary outcome focuses on the use of the AV1, social participation, and users’ perceived quality of life. Data collection via semi-structured interviews with the children and adolescents, as well as their parents, will take place approximately 6–8 weeks after the start of the intervention. In addition, factors that facilitated or hindered the use of the AV1 will be identified.	—

Secondary

Measure	Time frame
The secondary outcome is the assessment of user acceptance (children/adolescents and parents). This will be measured using the System Usability Scale (SUS) before the start of using av1 and after 3 months. In addition, factors that facilitated or hindered the use of the AV1 will be identified via the semi-structured interviews. At the participating schools, interviews will be conducted with teachers who have used the AV1 in their lessons and with classmates. These interviews will take place after the three-month use period has ended and are intended to provide insight into the schools’ experiences with the AV1. At the end of the study, a focus group interview will be held with the pediatric oncology treatment team to gather their experiences with the AV1 in the context of treatment for children and adolescents, as well as their perspectives on how the children and adolescents experienced using the AV1.	—

Measure

Time frame

The secondary outcome is the assessment of user acceptance (children/adolescents and parents). This will be measured using the System Usability Scale (SUS) before the start of using av1 and after 3 months. In addition, factors that facilitated or hindered the use of the AV1 will be identified via the semi-structured interviews. At the participating schools, interviews will be conducted with teachers who have used the AV1 in their lessons and with classmates. These interviews will take place after the three-month use period has ended and are intended to provide insight into the schools’ experiences with the AV1. At the end of the study, a focus group interview will be held with the pediatric oncology treatment team to gather their experiences with the AV1 in the context of treatment for children and adolescents, as well as their perspectives on how the children and adolescents experienced using the AV1.

—

Countries

Germany

Contacts

Public ContactNicole Reinsperger

AG Versorgungsforschung | Pflege im Krankenhaus, Department für Innere Medizin | Universitätsmedizin Halle

nicole.reinsperger@uk-halle.de+49 345 557 6558

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026